Biotech · Private company

Escient Pharmaceuticals, Inc

Track this companyFree. Adds Escient Pharmaceuticals, Inc to your Dealase workspace and tells you when its record changes.

Clinical trials50 recruiting or active

Pipeline programs5From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline5

An Open-Label Phase 1 Study in Healthy Male Subjects to Investigate the Absorption, Metabolism and Excretion of [14C]-EP262 Following Single-Dose Oral AdministrationPHASE1 · COMPLETED · started Oct 1, 2024ClinicalTrials.gov NCT06645704 · fetched Nov 12, 2026
Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic DermatitisPHASE2 · COMPLETED · started Oct 25, 2023ClinicalTrials.gov NCT06144424 · fetched Nov 12, 2026
Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous UrticariaPHASE2 · TERMINATED · started Sep 25, 2023ClinicalTrials.gov NCT06077773 · fetched Nov 12, 2026
Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible UrticariaPHASE1 · COMPLETED · started Aug 30, 2023ClinicalTrials.gov NCT06050928 · fetched Nov 12, 2026
Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing CholangitisPHASE2 · COMPLETED · started Oct 6, 2022ClinicalTrials.gov NCT05525520 · fetched Nov 12, 2026